Select Publications
Journal articles
1999, 'Carvedilol in class IV heart failure - Reply', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 34, pp. 2149 - 2150, http://dx.doi.org/10.1016/S0735-1097(99)00481-7
,1999, 'Left ventricular chamber function during inhaled nitric oxide in patients with dilated cardiomyopathy', Journal of Cardiovascular Pharmacology, 34, pp. 749 - 754, http://dx.doi.org/10.1097/00005344-199911000-00018
,1999, 'Inhaled nitric oxide in cardiology practice', Cardiovascular Research, 43, pp. 628 - 638, http://dx.doi.org/10.1016/S0008-6363(99)00114-5
,1999, 'ATP-sensitive potassium channel activation mimics the protective effect of ischaemic preconditioning in the rat isolated working heart after prolonged hypothermic storage', Clinical and Experimental Pharmacology and Physiology, 26, pp. 20 - 25, http://dx.doi.org/10.1046/j.1440-1681.1999.02985.x
,1999, 'Transcriptional down-regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulation', British Journal of Pharmacology, 126, pp. 103 - 110, http://dx.doi.org/10.1038/sj.bjp.0702280
,1999, 'Aggressive cutaneous malignancies following cardiothoracic transplantation', Cancer, pp. 1758 - 1764
,1999, 'Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure', Heart, pp. 589 - 593
,1999, 'Skin cancer in Australian heart transplant recipients', Journal of the American Academy of Dermatology, pp. 27 - 34
,1999, 'Tolerability and efficacy of carvediolol in patients with New York Heart Association Class IV heart failure', Journal of the American College of Cardiology, pp. 924 - 931
,1998, 'The nitric oxide donor, diethylamine NONOate, enhances preservation of the donor rat heart', Journal of Heart and Lung Transplantation, 17, pp. 1113 - 1120
,1998, 'Left atrial reduction: The forgotten Batista', Lancet, 351, pp. 879 - 880, http://dx.doi.org/10.1016/S0140-6736(05)70290-7
,1998, 'Exercise training improves symptoms, exercise capacity and neurohumoral abnormalities in moderate to severe heart failure', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 31, pp. 509A - 509A, http://dx.doi.org/10.1016/S0735-1097(97)88216-2
,1998, 'Adjunctive use of inhaled nitric oxide during implantation of a left ventricular assist device', Journal of Heart and Lung Transplantation, 17, pp. 312 - 316
,1998, 'Cardioprotective effects of pinacidil pretreatment and lazaroid (U74500A) preservation in isolated rat hearts after 12-hour hypothermic storage.', Transplantation, pp. 158 - 163
,1998, 'Cardiovascular ageing and heart failure', Medical Journal of Australia, 169, pp. 480 - 484
,1998, 'Exercise training improves symptoms, exercise capacity and neurohumoral abnormalities in moderate to severe heart failure', Journal of the American College of Cardiology, 31, pp. 509 - 509, http://dx.doi.org/10.1016/s0735-1097(98)80567-6
,1998, 'Ocular complications of heart, lung, and liver transplantation', British Journal of Ophthalmology, pp. 423 - 428
,1998, 'The nitric oxide donor, diethylamine NONOate enhances preservation of the donor heart', Journal of Heart and Lung Transplantation, pp. 158 - 163
,1997, 'Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension', Pneumologie, 51, pp. 995
,1997, 'Effect of calcitriol in the prevention of bone loss after cardiac or lung transplantation', JOURNAL OF BONE AND MINERAL RESEARCH, 12, pp. F696 - F696, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XP62701186&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Effect of inhaled nitric oxide on normal human left ventricular function', Journal of the American College of Cardiology, 30, pp. 49 - 56, http://dx.doi.org/10.1016/S0735-1097(97)00143-5
,1997, 'Characterization of the P
1997, 'Relationship between the walk tests and height, weight and body surface area in advanced heart failure', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 29, pp. 96668 - 96668, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WF76100693&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Assessment of endothelial function--go with the flow.', Australian and New Zealand journal of medicine, 27, pp. 637 - 638, http://dx.doi.org/10.1111/j.1445-5994.1997.tb00988.x
,1997, 'Papaverive abolishes endothelium-dependent dilatation of human paternal mammary arteries in vitro', Clinical and Experimental Pharmacology and Physiology, 24, pp. 223 - 228, http://dx.doi.org/10.1111/j.1440-1681.1997.tb01811.x
,1997, 'A model of chronic discordant xenograft rejection: Histological and functional changes in grafts surviving beyond hyperacute rejection', The Asia Pacific Heart Journal, 6, pp. 32 - 35, http://dx.doi.org/10.1016/s1328-0163(97)90077-4
,1997, 'Continuous amBulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy', American Journal of Cardiology, 134, pp. 889 - 900
,1997, 'Enhanced preservation of the rat heart after prolonged hypothermic storage with the21-aminosteriod U74500A', Asia Pacific Heart Journal, pp. 184 - 189
,1996, 'Ventricular effects of Inhaled nitric oxide in patients with impaired ventricular function.', CIRCULATION, 94, pp. 3208 - 3208, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VN11903198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1996, 'Inhaled nitric oxide in cardiac failure: Vascular versus ventricular effects', Journal of Cardiovascular Pharmacology, 27, pp. 80 - 85, http://dx.doi.org/10.1097/00005344-199601000-00013
,1996, 'Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension', Circulation, 94, pp. 477 - 482, http://dx.doi.org/10.1161/01.CIR.94.3.477
,1996, 'Changing concepts of endothelial dysfunction - the role of nitric oxide in cardiovascular disease', ACE Inhibition, pp. 2 - 3
,1996, 'Clinical heart transplantation. Total lymphoid irradiation for resistant rejection after heart transplantation: only moderate success medium-term.', J Heart Lung Transplant, 15, pp. 231 - 233, https://www.ncbi.nlm.nih.gov/pubmed/8777203
,1996, 'Ischemic preconditioning enhances donor lung preservation in the rat', Journal of Heart and Lung Transplantation, 15, pp. 1258 - 1267
,1996, 'The role of nitric oxide in heart failure: potential for pharmacological intervention', Drugs and Aging, pp. 452 - 458
,1996, 'Total lymphoid irradiation for resistant rejection after heart transplantation: only moderate success medium-term', Journal of Heart and Lung Transplantation, 15, pp. 231 - 233
,1995, 'Lazaroid U74500A enhances donor lung preservation in the rat transplant model', Transplantation Proceedings, 27, pp. 3574 - 3577
,1995, 'EVALUATION OF THE EFFECTS OF INHALED NITRIC-OXIDE ON NORMAL HUMAN LEFT-VENTRICULAR FUNCTION', CIRCULATION, 92, pp. 3805 - 3805, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995TB48003781&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1995, 'Bone mineral loss and recovery after cardiac transplantation [15]', Lancet, 346, pp. 905, http://dx.doi.org/10.1016/S0140-6736(95)92748-4
,1995, 'Bone mineral loss and recovery after cardiac transplantation', The Lancet, 346, pp. 905, http://dx.doi.org/10.1016/S0140-6736(95)92748-4
,1995, 'Ketoconazole to reduce the need for cyclosporine after cardiac transplantation', New England Journal of Medicine, 333, pp. 628 - 634, http://dx.doi.org/10.1056/NEJM199509073331004
,1995, 'IS CARDIOMYOPLASTY AN ALTERNATIVE TO CARDIAC TRANSPLANTATION', MEDICAL JOURNAL OF AUSTRALIA, 162, pp. 343 - 344, http://dx.doi.org/10.5694/j.1326-5377.1995.tb139932.x
,1995, 'A double-blind placebo-controlled trial of low-dose ganciclovir to prevent cytomegalovirus disease after heart transplantation', Journal of Heart and Lung Transplantation, 14, pp. 32 - 38
,1995, 'Nitric oxide production and heart failure', The Lancet, 345, pp. 390 - 391, http://dx.doi.org/10.1016/S0140-6736(95)90379-8
,1995, 'A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF LOW-DOSE GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER HEART-TRANSPLANTATION', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 14, pp. 32 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QH34900005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1995, 'Australia's first HeartMate recipient', Australian and New Zealand Journal of Medicine, 25, pp. 535 - 536, http://dx.doi.org/10.1111/j.1445-5994.1995.tb01502.x
,1995, 'Endogenous nitric oxide in cardiovascular disease and transplantation', Annals of Medicine, 27, pp. 395 - 406, http://dx.doi.org/10.3109/07853899509002593
,1995, 'HLA mismatching and outcome in heart, heart-lung, and single lung transplantation', Journal of Heart and Lung Transplantation, 14, pp. 444 - 451
,1995, 'Outcome in paired recipients of single lung transplants from the same donor', Journal of Heart and Lung Transplantation, 14, pp. 878 - 882
,1995, 'Pilot study of low-dose azathioprine in presensitized patients awaiting heart or lung transplantation', Journal of Heart and Lung Transplantation, 14, pp. 945 - 949
,